首页> 美国卫生研究院文献>Bioscience Reports >Analysis of miRNA signature differentially expressed in exosomes from adriamycin-resistant and parental human breast cancer cells
【2h】

Analysis of miRNA signature differentially expressed in exosomes from adriamycin-resistant and parental human breast cancer cells

机译:抗阿霉素和亲代人乳腺癌细胞外泌体中差异表达的miRNA特征的分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A major cause of failure in chemotherapy is drug resistance of cancer cells. Exosomes have been introduced to spread chemoresistance through delivering miRNAs. However, a systematic evaluation of the exosomal miRNA expression profiles responsible for chemoresistance is still lacking. In the present study, miRNA signature differentially expressed in exosomes derived from adriamycin-resistant (A/exo) and parental breast cancer cells (S/exo) were analyzed by microarray and the results were confirmed by PCR. A total of 309 miRNAs were increased and 66 miRNAs were decreased significantly in A/exo compared with S/exo. Specifically, 52 novel miRNAs with increased expression levels >16.0-fold in A/exo were identified. After prediction of target genes for 13 of 52 selected novel miRNAs, pathway analysis, gene ontology (GO) terms, and protein–protein interactions (PPIs) were constructed. The results implied that these selected exosomal miRNAs inhibited target genes involved in transcriptional misregulation in cancer, MAPK, and Wnt signaling pathways. Functional enrichment analysis demonstrated that the target genes were mainly responsible for protein phosphorylation, transcription regulation, molecular binding, and kinase activity. In summary, the current bioinformatics study of exosomal miRNAs may offer a new understanding into mechanisms of chemoresistance, which is helpful to find potential exosomal miRNAs to overcome drug insensitivity in future breast cancer treatment.
机译:化疗失败的主要原因是癌细胞的耐药性。已经引入外来体通过递送miRNA来传播化学抗性。然而,仍然缺乏对负责化学抗性的外泌体miRNA表达谱的系统评价。在本研究中,通过微阵列分析了在抗阿霉素(A / exo)和亲代乳腺癌细胞(S / exo)的外来体中差异表达的miRNA特征,并通过PCR证实了结果。与S / exo相比,A / exo中总共增加了309个miRNA,而显着减少了66个miRNA。具体而言,鉴定了52种在A / exo中表达水平增加> 16.0倍的新型miRNA。在预测了52种选定的新型miRNA中的13种靶基因后,构建了途径分析,基因本体论(GO)术语和蛋白质-蛋白质相互作用(PPI)。结果表明,这些选定的外泌体miRNA抑制了与癌症,MAPK和Wnt信号通路中的转录失调有关的靶基因。功能富集分析表明,靶基因主要负责蛋白质的磷酸化,转录调控,分子结合和激酶活性。总而言之,当前对外泌体miRNA的生物信息学研究可能会为化学抗药性机制提供新的认识,这有助于寻找潜在的外泌体miRNA来克服未来乳腺癌治疗中的药物敏感性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号